| Date Filed | Type | Description |
| 06/06/2023 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,010 shares
@ $0
Granted 15,324 options to buy
@ $22.84, valued at
$350k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $37.66, valued at
$376.6k
|
|
| 05/01/2020 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 11,037 shares
@ $0 |
|
| 06/04/2019 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $43.02, valued at
$430.2k
|
|
| 05/03/2019 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 10,633 shares
@ $23.51, valued at
$250k
|
|
| 05/30/2018 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $49.45, valued at
$618.1k
|
|
| 05/08/2018 |
4/A
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 13,881 shares
@ $0 |
|
| 05/04/2018 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 14,285 shares
@ $0 |
|
| 05/26/2017 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $18.85, valued at
$235.6k
|
|
| 05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2016 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Bought 4,000 shares
@ $24.65, valued at
$98.6k
|
|
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
3
| KARABELAS ARGERIS N (Director) has filed a Form 3 on Valeant Pharmaceuticals International, Inc. |
| 06/02/2016 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $12.74, valued at
$159.3k
|
|
| 09/22/2015 |
4/A
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 9,375 options to buy
@ $22, valued at
$206.3k
|
|
| 09/17/2015 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 5,208 options to buy
@ $22, valued at
$114.6k
|
|
| 06/26/2015 |
4
| KARABELAS ARGERIS N (10% Owner) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Granted 12,000 options to buy
@ $5.03, valued at
$60.4k
|
|
| 02/25/2015 |
4
| KARABELAS ARGERIS N (10% Owner) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Converted 1,394,645 shares
@ $0
Converted 63,560 shares
@ $0
Bought 603,832 shares
@ $6, valued at
$3.6M
Converted 4,459,658 options to buy
@ $0
Converted convertible notes
@ $0 |
|
| 08/01/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/11/2012 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 728 shares
@ $13.64, valued at
$9.9k
|
|
| 05/21/2012 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 16,000 options to buy
@ $14.23, valued at
$227.7k
|
|
| 04/12/2012 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 1,120 shares
@ $7.53, valued at
$8.4k
|
|
| 07/11/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2011 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 16,000 options to buy
@ $27.51, valued at
$440.2k
|
|
| 04/13/2011 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Granted 308 shares
@ $28.74, valued at
$8.9k
|
|
| 06/07/2010 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.38, valued at
$110.7k
|
|
| 05/25/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|